FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023681515> ?p ?o ?g. }

• W2023681515 endingPage "431" @default.
• W2023681515 startingPage "424" @default.
• W2023681515 abstract "Abstract Background: The HER-2 receptor undergoes a proteolytic cleavage generating an NH2-terminally truncated fragment, p95HER-2, that is membrane-associated and tyrosine-phosphorylated. We have reported that p95HER-2, but not the full-length receptor, p185HER-2, correlated with the extent of lymph node involvement in patients with breast cancer and its expression was significantly enhanced in nodal metastatic tissue. These facts suggested an important role for p95HER-2 either as a marker or cause of metastasis and poor outcome in breast cancer. In this work, we have studied the prognostic value of p95HER-2 in breast cancer. Methods: Primary breast tumor tissues (n = 483) were from surgical resections conducted in hospitals in two different countries: the U.S. (n = 334) and Spain (n = 149). HER-2 protein forms, including p185HER-2 and p95HER-2, were examined in extracts of primary breast tumors by Western blot analysis. The levels of the two forms (high or low) were tested for association with other clinicopathologic factors and for correlation with disease-free survival. Results: The median follow-up was 46 months. A high level of p95HER-2 in primary tumor tissue correlated with reduced 5-year disease-free survival (hazard ratio, 2.55; 95% confidence interval, 2.13-8.01; P &lt; 0.0001). The median time for disease-free survival was 32 versus 139 months in patients with low levels of p95HER-2. In comparison, high levels of the full-length p185HER-2 did not significantly correlate with poor outcome (P &gt; 0.1). Multivariate analysis revealed that high p95HER-2 was an independent predictor of disease-free survival (hazard ratio, 1.59; 95% confidence interval, 1.246-1.990; P = 0.0004). Conclusions: p95HER-2 expression is an independent prognostic factor in breast cancer and defines a group of patients with HER-2-positive breast cancer with significantly worse outcome." @default.
• W2023681515 created "2016-06-24" @default.
• W2023681515 creator A5000799305 @default.
• W2023681515 creator A5010057496 @default.
• W2023681515 creator A5011012477 @default.
• W2023681515 creator A5012974257 @default.
• W2023681515 creator A5014510882 @default.
• W2023681515 creator A5026179323 @default.
• W2023681515 creator A5028275481 @default.
• W2023681515 creator A5029048001 @default.
• W2023681515 creator A5033981988 @default.
• W2023681515 creator A5076170054 @default.
• W2023681515 date "2006-01-15" @default.
• W2023681515 modified "2023-10-16" @default.
• W2023681515 title "p95HER-2 Predicts Worse Outcome in Patients with HER-2-Positive Breast Cancer" @default.
• W2023681515 cites W1491740602 @default.
• W2023681515 cites W1901376003 @default.
• W2023681515 cites W1922272927 @default.
• W2023681515 cites W1965649407 @default.
• W2023681515 cites W1968961303 @default.
• W2023681515 cites W1974024530 @default.
• W2023681515 cites W1979766088 @default.
• W2023681515 cites W1984375602 @default.
• W2023681515 cites W1985103368 @default.
• W2023681515 cites W1995788690 @default.
• W2023681515 cites W1999513758 @default.
• W2023681515 cites W2001627828 @default.
• W2023681515 cites W2004755792 @default.
• W2023681515 cites W2005084132 @default.
• W2023681515 cites W2011711731 @default.
• W2023681515 cites W2018843265 @default.
• W2023681515 cites W2024226643 @default.
• W2023681515 cites W2033764434 @default.
• W2023681515 cites W2049506505 @default.
• W2023681515 cites W2056581335 @default.
• W2023681515 cites W2062874020 @default.
• W2023681515 cites W2063749929 @default.
• W2023681515 cites W2065064603 @default.
• W2023681515 cites W2073385822 @default.
• W2023681515 cites W2112720107 @default.
• W2023681515 cites W2113359881 @default.
• W2023681515 cites W2140452388 @default.
• W2023681515 cites W2161428561 @default.
• W2023681515 cites W2162669436 @default.
• W2023681515 cites W2165373113 @default.
• W2023681515 cites W2167167632 @default.
• W2023681515 cites W4242975645 @default.
• W2023681515 cites W4293149735 @default.
• W2023681515 doi "https://doi.org/10.1158/1078-0432.ccr-05-1807" @default.
• W2023681515 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16428482" @default.
• W2023681515 hasPublicationYear "2006" @default.
• W2023681515 type Work @default.
• W2023681515 sameAs 2023681515 @default.
• W2023681515 citedByCount "196" @default.
• W2023681515 countsByYear W20236815152012 @default.
• W2023681515 countsByYear W20236815152013 @default.
• W2023681515 countsByYear W20236815152014 @default.
• W2023681515 countsByYear W20236815152015 @default.
• W2023681515 countsByYear W20236815152016 @default.
• W2023681515 countsByYear W20236815152017 @default.
• W2023681515 countsByYear W20236815152018 @default.
• W2023681515 countsByYear W20236815152019 @default.
• W2023681515 countsByYear W20236815152020 @default.
• W2023681515 countsByYear W20236815152021 @default.
• W2023681515 countsByYear W20236815152022 @default.
• W2023681515 countsByYear W20236815152023 @default.
• W2023681515 crossrefType "journal-article" @default.
• W2023681515 hasAuthorship W2023681515A5000799305 @default.
• W2023681515 hasAuthorship W2023681515A5010057496 @default.
• W2023681515 hasAuthorship W2023681515A5011012477 @default.
• W2023681515 hasAuthorship W2023681515A5012974257 @default.
• W2023681515 hasAuthorship W2023681515A5014510882 @default.
• W2023681515 hasAuthorship W2023681515A5026179323 @default.
• W2023681515 hasAuthorship W2023681515A5028275481 @default.
• W2023681515 hasAuthorship W2023681515A5029048001 @default.
• W2023681515 hasAuthorship W2023681515A5033981988 @default.
• W2023681515 hasAuthorship W2023681515A5076170054 @default.
• W2023681515 hasConcept C121608353 @default.
• W2023681515 hasConcept C126322002 @default.
• W2023681515 hasConcept C142724271 @default.
• W2023681515 hasConcept C143998085 @default.
• W2023681515 hasConcept C207103383 @default.
• W2023681515 hasConcept C2775930923 @default.
• W2023681515 hasConcept C2778001805 @default.
• W2023681515 hasConcept C2779013556 @default.
• W2023681515 hasConcept C2780849966 @default.
• W2023681515 hasConcept C44249647 @default.
• W2023681515 hasConcept C50382708 @default.
• W2023681515 hasConcept C530470458 @default.
• W2023681515 hasConcept C71924100 @default.
• W2023681515 hasConcept C90924648 @default.
• W2023681515 hasConceptScore W2023681515C121608353 @default.
• W2023681515 hasConceptScore W2023681515C126322002 @default.
• W2023681515 hasConceptScore W2023681515C142724271 @default.
• W2023681515 hasConceptScore W2023681515C143998085 @default.
• W2023681515 hasConceptScore W2023681515C207103383 @default.
• W2023681515 hasConceptScore W2023681515C2775930923 @default.
• W2023681515 hasConceptScore W2023681515C2778001805 @default.

• next